| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.01 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |